Teleflex (TFX) Expected to Announce Earnings on Thursday

Teleflex (NYSE:TFX) is expected to announce its Q1 2026 results before the market opens on Thursday, April 30th. Analysts expect the company to announce earnings of $1.21 per share and revenue of $532.0780 million for the quarter. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Parties are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, April 30, 2026 at 8:00 AM ET.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.73 by ($1.80). The business had revenue of $569.00 million for the quarter, compared to analyst estimates of $912.57 million. Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The company’s quarterly revenue was down 28.5% on a year-over-year basis. During the same period in the prior year, the company earned $3.89 earnings per share. On average, analysts expect Teleflex to post $7 EPS for the current fiscal year and $10 EPS for the next fiscal year.

Teleflex Stock Up 11.2%

Teleflex stock opened at $138.73 on Thursday. The business’s 50-day simple moving average is $115.56 and its two-hundred day simple moving average is $116.39. The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.01 and a current ratio of 2.54. The company has a market cap of $6.14 billion, a PE ratio of -6.75, a PEG ratio of 0.90 and a beta of 0.84. Teleflex has a fifty-two week low of $100.18 and a fifty-two week high of $139.67.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex’s dividend payout ratio is currently -6.62%.

Wall Street Analyst Weigh In

TFX has been the topic of a number of recent research reports. Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price on the stock in a research note on Monday, April 13th. Royal Bank Of Canada restated a “sector perform” rating on shares of Teleflex in a research note on Tuesday, April 14th. Zacks Research downgraded Teleflex from a “hold” rating to a “strong sell” rating in a research note on Monday, March 2nd. Wells Fargo & Company upped their target price on Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a research note on Friday, February 27th. Finally, Wall Street Zen downgraded Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. Three equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $138.50.

Hedge Funds Weigh In On Teleflex

A number of large investors have recently bought and sold shares of the business. AQR Capital Management LLC raised its holdings in Teleflex by 478.1% in the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after purchasing an additional 1,956,811 shares during the period. State Street Corp raised its holdings in Teleflex by 1.5% in the 4th quarter. State Street Corp now owns 1,478,776 shares of the medical technology company’s stock worth $180,470,000 after purchasing an additional 22,111 shares during the period. Dimensional Fund Advisors LP raised its holdings in Teleflex by 0.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,250,665 shares of the medical technology company’s stock worth $152,630,000 after purchasing an additional 5,051 shares during the period. Abrams Bison Investments LLC raised its holdings in Teleflex by 5.6% in the 4th quarter. Abrams Bison Investments LLC now owns 969,000 shares of the medical technology company’s stock worth $118,257,000 after purchasing an additional 51,075 shares during the period. Finally, Fuller & Thaler Asset Management Inc. raised its holdings in Teleflex by 21.3% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 696,950 shares of the medical technology company’s stock worth $85,056,000 after purchasing an additional 122,481 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.